Fig. 4. SNHG12 promoted tumour progression via CDCA3 in RCC cells.
a CCK-8 assays showed overexpressing CDCA3 reversed the proliferation-inhibition effect of si SNHG12 and knockdown CDCA3 reversed the proliferation-promoting effect of SNHG12 overexpression in ACHN and 786-O cells. b Migration and invasion ability attenuated by sh SNHG12 could be reversed by CDCA3 overexpression in ACHN and 786-O cells according to transwell assays (magnification: ×100). c Migration and invasion ability promoted by SNHG12 could be reversed by si CDCA3 according to transwell assays (magnification: ×100). d, e Cell cycle distribution was analysed by PI staining in ACHN and 786-O cells after co-transfection by sh SNHG12 and CDCA3 overexpression vector or SNHG12 overexpression vector and si CDCA3 for 48 h. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Error bars indicate mean ± SD.